Navigation Links
Rheumatoid Arthritis Drug Lowers Flu Shot Effectiveness
Date:1/11/2010

But patients should still get vaccinated, researchers say

MONDAY, Jan. 11 (HealthDay News) -- New research offers a caution to rheumatoid arthritis patients who take the drug rituximab (Rituxan): The flu vaccine is safe, but it's ineffective during the first six months following treatment with Rituxan.

The researchers also found that previous flu vaccination does help provide some protection against the flu, and the vaccine won't make the arthritis symptoms worse.

The study findings are published in the January issue of Arthritis & Rheumatism.

Rheumatoid arthritis, which is caused when the immune system attacks the body, affects about 4.6 million people around the world. Doctors recommend that these patients get vaccinated against influenza each year -- including the H1N1 swine flu this year -- because they have weakened immune systems.

The new study, by Dr. Sander van Assen and colleagues at the University Medical Center Groningen in the Netherlands, included rheumatoid arthritis patients who took rituximab or methotrexate, as well as a group of healthy people.

Those who took rituximab took longer to develop immunity to flu after being vaccinated, the researchers found.

"Individuals who have compromised immune systems, such as with rheumatoid arthritis, are at risk for complications from contracting the flu virus," van Assen said in a news release from the American College of Rheumatology. "We recommend yearly influenza vaccination for all rheumatoid arthritis patients and pre-emptive vaccination for flu should be considered by those patients who start rituximab treatment."

More information

The U.S. Centers for Disease Control and Prevention has more about the flu.



-- Randy Dotinga



SOURCE: American College of Rheumatology, news release, Jan. 6, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. UAB creates national network to advance personalized medicine in rheumatoid arthritis
2. CEL-SCI Presents Data at American College of Rheumatology Conference Which Suggests that CEL-2000 Has Potential to Slow Damage Caused by Rheumatoid Arthritis
3. Video: Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA)
4. Jane Seymour Lends Support to Recognise the Hopes and Achievements of People Living With Rheumatoid Arthritis (RA)
5. Experimental approach may reverse rheumatoid arthritis and osteoporosis
6. Asian Countries Cannot Afford To Ignore the Cost of Rheumatoid Arthritis
7. Studies show dramatic decline in rheumatoid vasculitis in US veterans
8. Herb Shows Potential for Rheumatoid Arthritis
9. TNF Blockers May Help Some With Rheumatoid Arthritis
10. Decision Resources Updated Rheumatoid Arthritis Report Now Includes Forecast for Rigel Pharmaceuticals Fostamatinib Disodium
11. Lexicon Initiates Phase 2 Clinical Trial of LX2931 in Patients With Rheumatoid Arthritis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... ... February 12, 2016 , ... Basketball is a game for everyone, not ... Peety PoppersTM series, sign language translation is featured in the top right of the ... Peety PoppersTM lessons has a sign language translator to teach kids the game and ...
(Date:2/11/2016)... ... February 12, 2016 , ... Fitbody Personal Training offers outdoor training ... exciting way to get fit and healthy. Located in Phoenixville, PA, the classes are ... class designed for horseback riders who want to lose weight and tone up. This ...
(Date:2/11/2016)... (PRWEB) , ... February 11, 2016 , ... ... participated in the American Osteopathic Association’s (AOA) Match Program Tuesday, February 9, taking ... Program places students into osteopathic graduate medical education positions across the country. Of ...
(Date:2/11/2016)... ... February 12, 2016 , ... The Journal of ... from 0.416 in 2013. The SJR uses data taken from the Scopus database (Elsevier ... the number of citations received by the journal over a three year period and ...
(Date:2/11/2016)... ... February 11, 2016 , ... ... diabetes has been gearing up for their simultaneous grand openings in March. All ... right now that you’re probably wondering, is reversing diabetes possible? According to this ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... and Company (NYSE: LLY ) today announced that the ... patent would not presently be infringed by Actavis marketing pemetrexed ... Italy and Spain ... --> --> In ... Lilly,s patent would be indirectly infringed by Actavis marketing certain ...
(Date:2/12/2016)... , Feb. 12, 2016  Apellis Pharmaceuticals, ... a $47.1 million Series D preferred stock ... Management, Hillhouse Capital Group and venBio Global ... Investments, AJU IB Investment, and Epidarex Capital. The ... to further advance clinical trials in the ...
(Date:2/11/2016)... 11, 2016 The primary goal of this ... patterns on the usage of liquid biopsy. Key information ... - Timeframe of liquid biopsy adoption amidst future ... Evs—by organization type - Sample inflow to conduct liquid ... stool, serum, and so on. - Correlation analysis of ...
Breaking Medicine Technology: